Acute toxicity, lipid peroxidation and ameliorative properties of Alstonia boonei ethanol leaf extract on the kidney markers of alloxan induced diabetic rats by Enechi, OC et al.
 
 
Vol. 13(5), pp. 678-682, 29 January, 2014  
DOI: 10.5897/AJB2013.12803 
ISSN 1684-5315 ©2014 Academic Journals  
http://www.academicjournals.org/AJB 






Full Length Research Paper 
 
Acute toxicity, lipid peroxidation and ameliorative 
properties of Alstonia boonei ethanol leaf extract on the 
kidney markers of alloxan induced diabetic rats 
 
Enechi, O.C.*, Oluka, Ikenna H. and Ugwu, Okechukwu P.C. 
 
Department of Biochemistry, University of Nigeria, Nsukka, Enugu State, Nigeria. 
 
Accepted 20 January, 2014 
 
The lethal toxicity and lipid peroxidation studies of Alstonia boonei on alloxan induced diabetic rats 
were analysed. The effect of ethanol leaf extract of A. boonei on the kidney markers of diabetic rat was 
also determined. The acute toxicity of the ethanol extract of A. boonei was found to be more than 5000 
mg/kg body weight of the extract after 24 h of constant observation. The malondialdehyde 
concentration of the rats treated with 200 and 400 mg/kg body weights of the extract significantly 
decreased (p<0.05) when compared with the untreated diabetic rats. There was no significant difference 
(p>0.05) when malondialdehyde concentrations of rat treated with 200 and 400 mg/kg body weights of 
the extracts were compared with the standard control. But the creatinine concentration decreased 
significantly (p<0.05) when 200 and 400 mg/kg body weights of the extract of the treated diabetic 
animals were compared with the diabetic control. 
 





Diabetes mellitus represents a group of metabolic 
disorders in which there is an impaired glucose utilization 
inducing hyperglycemia which is an increase in the blood 
group level beyond normal values (Hazuda, 1991; Adonu 
et al., 2013). Diabetes is a chronic disease characterized 
by elevated blood glucose level and disturbances in 
carbohydrate, fat and protein metabolism (Sky, 2000; 
Rother, 2007; Andrew et al., 2013). In the local markets 
in West and Central Africa, Alstonia boonei is often 
among the most common sold plant as crude drugs. 
Parts of the plant are employed for the treatment of a 
variety of ailments in Africa and the stem bark has been 
listed in the Africa Pharmacopoeia as  an antimalarial 
drug (Bello et al ., 2009). 
A. boonei is a popular plant (Figure 1). It has many 
medicinal properties such as antifungal, antibacterial, 
anti-inflammatory, antiplasmodial, antimalarial, antipyretic, 
analgesic and hypotensive effects (Olajide et al., 2000). 
In this study, acute toxicity of A. boonei ethanol leaf 
extract and the effects of A. boonei ethanol leaf extract 
on the kidney markers and lipid peroxidation of diabetic 
rats were evaluated. 
 
 






Matured leaves of A. boonei were collected in Nsukka environs, 
Enugu State of Nigeria. The plants were identified and authentic-
cated by Mr. A. Ozioko of Bioresource Development and Conser-
vation Programme (BDCP) Research Centre, Nsukka, where the 
voucher specimens were deposited in the herbarium of the Depart-
ment of Botany, University of Nigeria, Nsukka. 
 

















Adult Wistar albino rats of between 10 and 16 weeks with average 
weight of 160 ± 13 g were obtained from the Animal House of the 
Faculty of Biological Sciences, University of Nigeria, Nsukka. The 
animals were acclimatised for 7 days under standard environmental 
conditions, with a 12 h light/dark cycle maintained on a regular feed 





All chemicals used in this study were of analytical grade and pro-
ducts of May and Baker, England; BDH, England and Merck, 
Darmstadt, Germany. Reagents used for all the assays were 
commercial kits and products of Randox, USA; Teco (TC), USA; 
Biosystem Reagents and Instruments, Spain; Glucose Analyzer, 
Accu Chek Active of Germany; alloxanmonohydrate, Sigma St. 





Water bath (Gallenkamp, England), Chemical Balance (Gallenkamp, 
England), Conical Flasks (Pyrex, England), Hotbox (Gallenkamp, 
England), Centrifuge (3,500 rpm, PIC, England), Digital Photo Calo-
rimeter (EI 312 Model, Japan), Adjustable Micropipette (Perfect, 
U.S.A.), Refrigerator (Kelvinator, Germany), pH Meter (Pye, Unicam 
293, England), multi-well microtiter plate reader (Tecan, Austria), 







A total of twenty eight (28) albino Wistar rats were divided into 
seven (7) groups of four (4) rats each. The animals were grouped 
as follows: Group 1: (Reference/normal control): Rats were fed with 
normal  diet  and  water  ad libitum; Group 2: diabetic untreated rats 




(diabetic control); Group 3: rats were administered with 2 mg/kg 
b.w. of glibenclamide (standard drug/control); Group 4, diabetic rats 
were administered with low dose (200 mg/kg b. w.) of the ethanol 
leaf extract of A. boonei; Group 5: diabetic rats were administered 
with high dose (400 mg/kg b. w.) of the ethanol leaf extract of A. 
boonei; Group 6: normal rats were administered with low dose (200 
mg/kg b. w.) of the ethanol leaf extract of A. boonei; Group 7: 
normal rats were administered with high dose (400 mg/kg b. w.) of 
the ethanol leaf extract of A. boonei. 
 
 
Collection and preparation of extracts 
 
Matured leaves of A. boonei were obtained from the environs of 
Nsukka Local Government Area, of Enugu State of Nigeria. 
Specimens of these leaves were authenticated in the Department of 
Bioresource Development and Conservation Programme (BDCP) 
Research Centre, Nsukka, and voucher specimens deposited in the 
herbarium. Leaves of A. boonei were separately dried under shade 
for 7 days, and then pulverized into powder. A weight of 208.1 g of 
the sample (powder) was agitated in 70% ethanol organic solvent 
for 48 h. The macerated extract was filtered with a cheese cloth and 
the filtrates concentrated in vacuo to 10% of the original volume at 
40°C. Concentrates were dried at 37°C to obtain percentage extract 
yield (35%) of the crude extract from the leaves of A. boonei. The 
extracts were reconstituted prior to administration. 
 
 
Induction of experimental diabetes  
 
Diabetes was induced by intraperitoneal injection of 120 mg/kg 
body weight of alloxanmonohydrate (Sigma St. Louis, MO, USA) in 
overnight-fasted animals after acclimatization. Diabetes was con-
firmed five (5) to eight (8) days later in the alloxan-treated animals 
showing random blood glucose (RBG) level ≥200mg/dl (11.1 
mmol/L). Diabetes status determination was monitored on blood 
obtained from tail vein puncture using an automated glucose sensor 
machine GlucometerAnalyser (Accu Chek Active). 
 
 
Determination of extract yield  
 
The percentage yield of the ethanol extract of leaves of A. boonei 
was determined by weighing the pulverized leaf powder before 
extraction and the concentrated extract was obtained after extrac-





Toxicological studies                
 
Acute toxicity and lethality (LD50) test  
 
Acute toxicity (LD50) of the ethanol extract of A. boonei leaves were 
determined by Lorke’s method (1983). A total of eighteen (18) adult 
albino mice were used for this investigation. The studies were 
conducted in two stages. In the first stage, three groups of three 
mice each were administered (p.o.) 10, 100, 1000 mg/kg body 
weight of the extract, respectively. The mice were observed for 24 h 
for a number of death and behavioural changes. In the second 
stage, based on the percentage survival rates, further increased 
doses of 1600, 2900 and 5000 mg/kg body weight were adminis-
tered (p.o.) to three additional mice for each group, respectively, 
and the fourth mice received only solvent (5% Tween80) which 
served as the control. The mice were observed for 24 h and the 
number of deaths was recorded. The LD50 was calculated as the geo
                                   Weight of leaf powder 
 Percentage yield =                                               × 100 
                                    Weight of extract 
 




Table 1. The percentage yield of ethanol extract of Alstonia boonei leaves. 
 
Initial weight of ground leaf powder (g) Final weight of extract (g) Percentage (%) 




Table 2. Results of the acute toxicity (LD50 ) of the ethanol extract of Alstonia boonei leaves. 
 
Dose ( mg/kg body weight) No. of animals before oral administration No. of deaths after administration 
10 3 - 
100 3 - 
1000 3 - 
1900 3 - 
2600 3 - 








Determination of serum urea concentration 
 
The concentration of serum urea was determined using the method 
of Tietz (1994) as outlined in Randox kits, UK. 
 
 
Determination of serum creatinine concentration 
 
The concentration of serum creatinine was determined using the 
method of Tietz (1994) as outlined in Randox kits, UK.  
 
 
Determination of lipid peroxidation (malondialdehyde, MDA)  
 
The concentration of malondialdehyde was determined using the 





Data were reported as means ± SEM, where appropriate. Both one- 
and two-way analyses of variance (ANOVA) were used to analyse 
the experimental data and Duncan multiple test range was used to 
compare the group means obtained after each treatment with 
control measurements. Differences were considered significant 





Percentage yield of the extract 
 
From the result in Table 1, the (%) yield of the ethanol 
extract of A. boonei leaves was found to be 12.64%. 
 
 
Acute toxicity studies of Alstonia boonei leaves  
 
The acute toxicity studies (LD50) of the ethanol extract of 
A. boonei leaves showed that no animal died in any 
group after receiving increasing doses (between 10 and 
5000 mg/kg b.w.) of the ethanol extract of A. boonei 
leaves (Table 2). 
Effects of the ethanol extract of Alstonia boonei 
leaves on urea concentration in normal and diabetic 
rats 
 
Results in Figure 2 showed neither significant increase 
nor decrease (p>0.05) in the urea concentration of the 
diabetic animals administered with 200 mg/kg b.w. of the 
extract compared with the normal control. Significantly 
elevated (p<0.05) concentration of urea was observed in 
the 400 mg/kg b.w of extract treated diabetic rats 
compared with the normal control. The 200 and 400 
mg/kg b.w. of extract treated diabetic animals showed no 
significant increase or decrease (p>0.05) compared to 
the diabetic control (group 2) as shown in Figure 2. The 
diabetic animals treated with low and high doses of the 
extract (200 and 400 mg/kg b.w.) showed significant 
decrease (p<0.05) and increase (p<0.05), respectively, 
compared with the diabetic animals treated with the 
standard drug. The normal animals administered low and 
high doses (200 and 400 mg/kg b.w.) of the extract 
showed no significant difference compared with the 
normal and diabetic controls (Groups 1 and 2) as shown 
in Figure 2. Interestingly, the 200 mg/kg b.w. treated 
normal animals showed a significant depreciation 
(P<0.05) in urea concentration compared with the 
glibenclamide-treated diabetic animals (standard control). 
 
 
Effects of ethanol extract of Alstonia Boonei leaves 
on creatinine concentration in normal and diabetic 
animals 
 
Creatinine concentration decreased significantly (P<0.05) 
in the animals treated with low dose (200 mg/kg b.w.) of 
the extract compared with the standard control as shown 
in Figure 3. There was no significant increase or de-
crease (P>0.05) in the creatinine concentration of both 
the 200 and 400 mg/kg b.w. treated diabetic animals as 
compared with the diabetic control. There was, however, 








Figure 2. Effect of ethanol leaf extract of Alstonia boonei on the 
urea concentration of normal and diabetic rats. Group 1: Normal 
control; Group 2: diabetic control (Untreated); Group 3: diabetic + 
glibenclamide; Group 4: diabetic + 200 mg/kg of extract; Group 5: 
diabetic + 400 mg/kg of extract; Group 6: 200 mg/kg of extract; 




tion of the diabetic animals administered high dose (400 
mg/kg b.w.) of the extract compared with the normal con-
trol as shown in Figure 3. 
 
 
Effects of the ethanol extract of Alstonia Boonei 
leaves on malondialdehyde (MDA) concentration in 
normal and diabetic rats 
 
Observation carried out in Figure 4 reveals significant 
decrease (p<0.05) in the MDA concentration of the dia-
betic rats treated with low and high (200 and 400 mg/kg 
b.w.) doses of the extract compared with the diabetic and 
control (Group 2). There was however no significant dif-
ference (p>0.05) in the MDA concentration of these 
diabetic test animals (Groups 4 and 5) compared with the 
normal and standard controls. There was a significantly 
elevated (p<0.05) concentration of MDA in the untreated 
diabetic rats (Group 2) compared with the rats adminis-
tered with the standard drug. It is also pertinent to men-
tion that the MDA concentration of the normal rats admi-
nistered 400 mg/kg b.w. of the extract increased signi-
ficantly (p<0.05) compared with the normal and standard 
controls. The normal rats administered 400 mg/kg b.w. of 






Figure 3. Effect of ethanol leaf extract of Alstonia boonei on the 
creatinine concentration of normal and diabetic rats. Group 1: 
Normal control; Group 2: diabetic control (untreated); Group 3: 
diabetic + glibenclamide; Group 4: diabetic + 200 mg/kg of 
extract; Group 5: diabetic + 400 mg/kg of extract; Group 6: 200 




the extract also showed a significantly elevated (p<0.05) 
MDA concentration compared with the diabetic rats trea-
ted with low and high doses of the extract, and the nor-
mal rats administered low dose (200mg/kg) of the extract 





Ayurvedic system of medicine relies on the administration 
of crude extract or concentration of crude extract of the 
plant material for the treatment of diabetes mellitus 
(Salahuddin and Jalalpure, 2010). Literature survey indi-
cates that there is no scientific evidence to support the 
antidiabetic effect of A. boonei. Therefore, the present 
study is undertaken to investigate acute toxicity of A. 
boonei ethanol leaf extract and the effects of A. boonei 
ethanol leaf extract on the kidney markers and lipid 
peroxidation of diabetic rats. In severe diabetic 
conditions, the kidneys lose their ability to remove wastes 
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Figure 4. Effect of Ethanol leaf extract of Alstonia boonei on the 




products, such as creatinine and urea, from the blood. 
From the result of the acute toxicity test of the ethanol 
extract of A. boonei leaves in mice, none of the mice died 
in any of the groups administered 10, 100, 1000, 1900, 
2600 and 5000 mg/kg b.w. of the extract after 24 h. 
Consequently, it could be suggested that the ethanol 
extract of A. boonei leaves could be generally regarded 
as safe (GRAS) (Lorke, 1984). However, further studies 
are needed to ascertain the effects of prolonged feeding 
of high doses of the extract on the organs and tissues of 
experimental animals.  
It was also observed that the extract had no reparatory 
effect on urea and creatinine excretion by the kidney in 
the diabetic animals since there was no significant dif-
ference (p>0.05) in the urea concentration of the treated 
diabetic animals compared with the diabetic control. 
Interestingly, the MDA concentration of the 200 and 400 
mg/kg b.w. treated diabetic rats showed a significant 
decrease (p<0.05) compared with the untreated diabetic 
rats. There was no observed significant difference 
(p>0.05) in MDA concentration of the treated diabetic rats 
compared with the standard control. This shows that the 
extract was able to prevent lipid peroxidation by reducing 
the action of the alloxan-induced free radicals. Conse-





has a potential antioxidant activity which can be a possi-
ble mechanism of its antidiabetic action. The flavonoids 
(antioxidants and free radical scavengers) in this plant 
may contribute to the effect of the plant extract in redu-
cing MDA concentration and concomitant lipid peroxide-
tion (Afolabi et al., 2007). The capacity of flavonoids to 
act as antioxidants depends on their molecular structure. 
The position of hydroxyl groups and other features in the 
chemical structure of flavonoids are important for their 
antioxidant and free radical scavenging activities. Quercetin, 
the most abundant dietary flavonol, is a potent antioxi-
dant because it has all the right structural features for 





In conclusion, the ethanol leaf extract of A. boonei has 
been shown to prevent lipid peroxidation and at the same 
time had no reparatory effects on the kidney markers. 
This prevention of lipid peroxidation could be the reason 
ethanol extracts of A. boonei leaf have been used in 
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